USPTO trademark

VALUMEDS

RegisteredUSPTOWord markClass 5

"VALUMEDS" is a word mark owned by Prodose, Inc., filed at the USPTO on April 6, 2017. It is registered and covers class 5 (Pharmaceuticals).

View Prodose, Inc. portfolio Get this data via the API

Data current as of October 25, 2026Official USPTO record

As filed with the USPTO

Status: Registered; Since June 26, 2023
Filed: April 6, 2017
Registered: October 24, 2017
Expires: Not recorded
Application no.: 87400993
Registration no.: 5316587
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 1 class

Ownership

Who owns VALUMEDS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Prodose, Inc.

Ronkonkoma, United States

5 trademarks in the portfolioView company

Representative

James J. Bitetto

Tutunjian & Bitetto, P.C.

Goods and services

What the mark covers

The products and services VALUMEDS is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Allergy medications; Allergy relief medication; [Amino acid preparations for medical purposes; Amino acids for nutritional purposes; Anesthetic for surgical purposes; Anesthetics for non-surgical use; Anesthetics for surgical and non-surgical use; Antibiotic creams; Antibiotic handwash; Antibiotic ointments; Antibiotic preparations; Antibiotic tablets; Antibiotics; Antifungal creams for medical use;] Antihistamines; [Calcium supplements; Contraceptive foams; Contraceptive preparations; Contraceptive sponges; Dental amalgams; Dental impression materials; Dental polish; Dental tablets for disclosing plaque and tartar on the teeth; Dental waxes; Deodorizing products, namely, all purpose deodorizer preparations for household, commercial and industrial use; Diagnostic agents, preparations and substances for medical purposes; Diagnostic preparations for medical purposes;] Diarrhea medication; [Diet capsules; Diet pills;] Dietary and nutritional supplements; [Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary supplements consisting primarily of calcium;] Dietary supplements for human consumption; [Electrolyte drinks for medical purposes; Electrolyte replacement solutions;] Enzyme dietary supplements; Enzymes for medical purposes; [Eye washes; Eye-washes; Fungicides for medical use; Hair growth stimulants; Hemorrhoid treatment preparations; Hemorrhoidal ointments;] Herbal supplements; [Herbal supplements for sleeping problems; Material for repairing teeth and for dental crowns and bridges; Medical lubricant, namely, vaginal lubricants; Medicated anti-cavity dental rinses; Medicated dental rinses; Medicated diaper rash ointments and lotions; Medicated hair care preparations; Medicated lotions for treating dermatological conditions; Medicines for dental purposes; Migraine treatment preparations; Mixed antibiotic preparations; Molding wax for dental use; Nail fungus treatment preparations; Nutritional supplements consisting primarily of calcium; Oral contraceptives; Orthodontic alginate for dental impressions;] Pain relief medication; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; [Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system, and for the treatment of inflammatory disorders, and for use in dermatology, oncology, hematology and in tissue and organ transplantation, and in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; ] Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; [Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for wounds;] Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; [Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceuticals, namely, anti-infectives; Room deodorants;] Sleeping pills/tablets [; Topical anesthetics; Vaginal preparations, namely, antifungals]

History

What has happened so far

Steps recorded by the USPTO, newest first.

October 25, 2026Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
February 12, 2025Automatic update of assignment of ownership
June 26, 2023Notice of acceptance of sec. 8 & 15 - e-mailed
June 26, 2023Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
June 14, 2023Case assigned to post registration paralegal
December 13, 2022Teas section 8 & 15 received
October 26, 2022Applicant/correspondence changes (non-responsive) entered
October 26, 2022Teas change of correspondence received
October 26, 2022Attorney/dom.rep.revoked and/or appointed
October 26, 2022Teas revoke/app/change addr of atty/dom rep received

10 earlier steps on the official record.

FAQ

About VALUMEDS

Who owns the trademark "VALUMEDS"?

The USPTO trademark "VALUMEDS" (application 87400993) is owned by Prodose, Inc.

What is the status of "VALUMEDS"?

Its status at the USPTO is: registered.

When was "VALUMEDS" registered?

It was registered on October 24, 2017.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull VALUMEDS and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2baf-91a2-71c9-b51f-85f0893248be
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2baf-91a2-71c9-b51f-85f0893248be",
  "object": "trademark",
  "mark_text": "VALUMEDS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "87400993",
  "filing_date": "2017-04-06",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "PRODOSE, INC.",
      "entity_id": "ent_019eb717-4d48-729d-ac70-99b808f57f0d"
    }
  ]
}